| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/14/2023 | 48.32% | RBC Capital | → $13 | Reiterates | Sector Perform → Sector Perform |
| 08/09/2023 | 14.09% | Citigroup | $9 → $10 | Maintains | Neutral |
| 08/09/2023 | 14.09% | Deutsche Bank | $5 → $10 | Maintains | Hold |
| 05/19/2023 | 48.32% | RBC Capital | → $13 | Reiterates | Sector Perform → Sector Perform |
| 05/15/2023 | 48.32% | RBC Capital | → $13 | Reiterates | Sector Perform → Sector Perform |
| 05/10/2023 | 14.09% | Credit Suisse | → $10 | Reiterates | → Neutral |
| 04/28/2023 | -20.14% | Citigroup | $10 → $7 | Maintains | Neutral |
| 03/08/2023 | 14.09% | Citigroup | $4.5 → $10 | Maintains | Neutral |
| 03/06/2023 | 48.32% | RBC Capital | $16 → $13 | Maintains | Sector Perform |
| 03/06/2023 | 14.09% | Credit Suisse | $4 → $10 | Maintains | Neutral |
| 08/15/2022 | 14.09% | Credit Suisse | $13 → $10 | Maintains | Neutral |
| 08/09/2022 | -8.73% | Truist Securities | $12 → $8 | Maintains | Hold |
| 08/09/2022 | 82.54% | RBC Capital | $17 → $16 | Maintains | Sector Perform |
| 05/04/2022 | 48.32% | Credit Suisse | $16 → $13 | Maintains | Neutral |
| 03/21/2022 | 71.14% | Citigroup | $37 → $15 | Downgrades | Buy → Neutral |
| 03/03/2022 | 82.54% | Credit Suisse | $31 → $16 | Maintains | Neutral |
| 03/02/2022 | 71.14% | Truist Securities | → $15 | Downgrades | Buy → Hold |
| 03/02/2022 | 71.14% | Evercore ISI Group | $35 → $15 | Downgrades | Outperform → In-Line |
| 01/07/2022 | 253.68% | Credit Suisse | $45 → $31 | Downgrades | Outperform → Neutral |
| 12/20/2021 | 322.13% | Citigroup | $45 → $37 | Maintains | Buy |
| 11/29/2021 | 116.77% | Deutsche Bank | $86 → $19 | Maintains | Hold |
| 11/10/2021 | 413.41% | Credit Suisse | $59 → $45 | Maintains | Outperform |
| 11/09/2021 | 276.5% | Craig-Hallum | → $33 | Downgrades | Buy → Hold |
| 11/09/2021 | 219.45% | RBC Capital | $62 → $28 | Maintains | Sector Perform |
| 07/30/2021 | 607.36% | RBC Capital | $70 → $62 | Maintains | Sector Perform |
| 07/30/2021 | 755.68% | Credit Suisse | $90 → $75 | Maintains | Outperform |
| 04/30/2021 | 926.81% | Credit Suisse | $78 → $90 | Maintains | Outperform |
| 03/25/2021 | 618.77% | Goldman Sachs | → $63 | Downgrades | Buy → Neutral |
| 03/23/2021 | 812.72% | Evercore ISI Group | $60 → $80 | Maintains | Outperform |
| 02/19/2021 | 618.77% | Deutsche Bank | → $63 | Downgrades | Buy → Hold |
| 02/02/2021 | 630.18% | Goldman Sachs | $101 → $64 | Maintains | Buy |
| 02/01/2021 | 641.59% | Craig-Hallum | $150 → $65 | Maintains | Buy |
| 02/01/2021 | 1040.9% | Truist Securities | $200 → $100 | Maintains | Buy |
| 02/01/2021 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 12/14/2020 | 1097.95% | SVB Leerink | $110 → $105 | Maintains | Outperform |
| 09/25/2020 | 1052.31% | Goldman Sachs | → $101 | Initiates Coverage On | → Buy |
| 09/08/2020 | 1154.99% | SVB Leerink | → $110 | Upgrades | Market Perform → Outperform |
| 07/27/2020 | 1212.04% | Raymond James | $165 → $115 | Maintains | Outperform |
| 07/24/2020 | 1679.81% | Credit Suisse | $174 → $156 | Maintains | Outperform |
| 07/24/2020 | 1497.26% | Barclays | $150 → $140 | Maintains | Overweight |
| 07/24/2020 | 1154.99% | SVB Leerink | $108 → $110 | Maintains | Market Perform |
| 07/14/2020 | 1440.22% | Citigroup | → $135 | Initiates Coverage On | → Buy |
| 07/01/2020 | 1132.17% | SVB Leerink | → $108 | Initiates Coverage On | → Market Perform |
| 04/27/2020 | 1839.53% | Deutsche Bank | $177 → $170 | Maintains | Buy |
| 04/16/2020 | 1611.35% | Barclays | → $150 | Initiates Coverage On | → Overweight |
| 02/24/2020 | 1942.21% | Credit Suisse | $145 → $179 | Maintains | Outperform |
| 02/24/2020 | 2752.25% | SunTrust Robinson Humphrey | $200 → $250 | Maintains | Buy |
| 02/21/2020 | 1919.4% | Deutsche Bank | $163 → $177 | Maintains | Buy |
| 02/21/2020 | 1793.9% | RBC Capital | $132 → $166 | Maintains | Outperform |
| 02/21/2020 | 2010.67% | Cantor Fitzgerald | $150 → $185 | Reiterates | → Overweight |
| 01/28/2020 | 1440.22% | Raymond James | $90 → $135 | Maintains | Outperform |
| 01/24/2020 | 1405.99% | RBC Capital | $111 → $132 | Maintains | Outperform |
| 01/24/2020 | 1611.35% | Craig-Hallum | $110 → $150 | Maintains | Buy |
| 01/24/2020 | 1554.31% | Credit Suisse | $134 → $145 | Maintains | Outperform |
| 01/24/2020 | 1611.35% | Cantor Fitzgerald | $120 → $150 | Reiterates | → Overweight |
| 10/15/2019 | 926.81% | Raymond James | → $90 | Initiates Coverage On | → Outperform |
| 09/12/2019 | 1873.76% | Deutsche Bank | → $173 | Initiates Coverage On | → Buy |
| 08/06/2019 | 1451.63% | Credit Suisse | $118 → $136 | Maintains | Outperform |
| 07/29/2019 | — | First Analysis | Upgrades | Outperform → Strong Buy | |
| 07/26/2019 | 1269.08% | Cantor Fitzgerald | $100 → $120 | Maintains | Overweight |
| 07/10/2019 | — | Credit Suisse | Initiates Coverage On | → Outperform | |
| 05/08/2019 | 1040.9% | Cantor Fitzgerald | $87 → $100 | Maintains | Overweight |
| 02/04/2019 | 755.68% | Evercore ISI Group | → $75 | Initiates Coverage On | → Outperform |
| 12/20/2018 | 550.31% | RBC Capital | → $57 | Initiates Coverage On | → Outperform |
| 08/16/2018 | 356.36% | Chardan Capital | → $40 | Initiates Coverage On | → Buy |
What is the target price for eHealth (EHTH)?
The latest price target for eHealth (NASDAQ: EHTH) was reported by RBC Capital on August 14, 2023. The analyst firm set a price target for $13.00 expecting EHTH to rise to within 12 months (a possible 48.32% upside). 11 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for eHealth (EHTH)?
The latest analyst rating for eHealth (NASDAQ: EHTH) was provided by RBC Capital, and eHealth reiterated their sector perform rating.
When is the next analyst rating going to be posted or updated for eHealth (EHTH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of eHealth, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for eHealth was filed on August 14, 2023 so you should expect the next rating to be made available sometime around August 14, 2024.
Is the Analyst Rating eHealth (EHTH) correct?
While ratings are subjective and will change, the latest eHealth (EHTH) rating was a reiterated with a price target of $0.00 to $13.00. The current price eHealth (EHTH) is trading at is $8.77, which is within the analyst's predicted range.